ArticleNanomaterials (Basel, Switzerland)2026
Cold Atmospheric Plasma Potentiates the Photodynamic Effects of Protoporphyrin IX-Loaded Mesoporous Silica-Coated Iron Oxide Nanoclusters in HaCaT Cells.
Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Photodynamic therapy (PDT) is a reactive oxygen species (ROS)-based treatment modality whose efficacy is often limited by poor photosensitizer stability and delivery. In this study, mesoporous silica-coated iron oxide nanoclusters (MNCs) were synthesized and loaded with protoporphyrin IX (PPIX) to obtain a multifunctional PPIX@MNC nanoplatform. Physicochemical characterization was performed using transmission electron microscopy (TEM), dynamic light scattering (DLS), zeta potential analysis, and Fourier-transform infrared spectroscopy (FTIR). The biological effects of MNC, free PPIX, and PPIX@MNC were evaluated in HaCaT cells-as a general epithelial model-under dark conditions, light irradiation, cold atmospheric plasma (CAP) exposure, and combined CAP-assisted photodynamic treatment. FTIR, DLS, and zeta potential analyses confirmed successful incorporation of PPIX into the nanoclusters. Cell viability assays revealed pronounced phototoxicity of free PPIX, with the IC50 value decreasing from 44.4 ± 3.5 nM under dark conditions to 14 ± 2 nM following light activation, corresponding to a phototoxicity index of 3.17. CAP further enhanced PPIX-mediated cytotoxicity, and the CAP-assisted photodynamic group exhibited the strongest response, with an IC50 value of 9.6 ± 1.1 nM. CAP further enhanced PPIX-mediated cytotoxicity. Increased ROS generation, enhanced apoptosis, and marked mitochondrial membrane potential disruption were observed particularly in CAP-Light-PPIX-treated cells. Although encapsulation of PPIX within MNCs reduced acute cytotoxicity compared with free PPIX, the nanoplatform retained responsiveness to light and CAP stimulation. These findings demonstrate that CAP potentiates PPIX-mediated photodynamic effects through enhanced oxidative stress and suggest that mesoporous silica-coated magnetic nanoclusters represent a promising platform for controlled photosensitizer delivery in CAP-assisted PDT applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.